RNA Sequencing

# RNA Sequencing * **Definition:** A technique used to determine the sequence of RNA molecules in a biological sample, providing insights into gene expression, cellular mechanisms, and genetic information. * **Taxonomy:** Healthcare Topics / RNA Sequencing ## News * Selected news on the topic of **RNA Sequencing**, for healthcare technology leaders * 3.4K news items are in the system for this topic * Posts have been filtered for tech and healthcare-related keywords | Date | Title | Source | | --- | --- | --- | | 5/21/2025 | [**miRNA Sequencing and Assays Market Research Report 2025-2030 with Focus on 25+ ...**](https://finance.yahoo.com/news/mirna-sequencing-assays-market-research-085600131.html) | [[Yahoo Finance]] | | 5/20/2025 | [**This Common Energy Drink Ingredient Could Increase Your Risk for Blood Cancer, New ...**](https://www.aol.com/lifestyle/common-energy-drink-ingredient-could-181727930.html) | [[AOL]] | | 5/19/2025 | [**There is no replacement (yet) for animal models in medical research - STAT News**](https://www.statnews.com/2025/05/19/animal-models-research-nih-biology-medical-breakthroughs-nobel-prize/) | [[STAT]] | | 4/22/2025 | [**Abbott and Danaher Among the Leaders in IVD Reagents Market with Innovation and Global Reach - Arizton**](https://www.theglobeandmail.com/investing/markets/markets-news/GetNews/31998083/abbott-and-danaher-among-the-leaders-in-ivd-reagents-market-with-innovation-and-global-reach-arizton/) | [[The Globe and Mail]] | | 3/13/2025 | [**New research uses AI to unravel the complex neuronal wiring of the motor system**](https://medicalxpress.com/news/2025-03-ai-unravel-complex-neuronal-wiring.html) | [[MedicalXpress]] | | 2/12/2025 | [**Glioblastoma Stem Cell and Myeloid-Derived Suppressor Cells: A Lethal Relationship that Drives Aggressive Growth**](https://www.insideprecisionmedicine.com/topics/oncology/glioblastoma-and-myeloid-derived-suppressor-cells-drive-aggressive-growth/) | [[Inside Precision Medicine]] | | 2/11/2025 | [**Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics ... - Yahoo Finance**](https://finance.yahoo.com/news/baylor-genetics-marks-decade-leadership-150000533.html) | [[Yahoo Finance]] | | 2/6/2025 | [**Scientific Investigation Combo Reveals Drug Repurposing Potential**](https://www.insideprecisionmedicine.com/topics/patient-care/scientific-investigation-combo-reveals-drug-repurposing-potential/) | [[Inside Precision Medicine]] | | 2/4/2025 | [**An atlas of cells in the human brain's control hub**](https://www.nature.com/articles/d41586-025-00314-w) | [[Nature]] | | 2/3/2025 | [**At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research ...**](https://www.morningstar.com/news/business-wire/20250203914935/at-scope-2025-concertai-announces-major-advances-in-trial-technologies-for-research-sites-and-sponsors) | [[Morningstar]] | | 12/19/2024 | [**Synthetic Biology Market Growth from 2024 to 2031, Projected at 12AGR, Highlighting ...**](https://www.linkedin.com/pulse/synthetic-biology-market-growth-from-2024-2031-projected-iyxhf) | [[Linkedin]] | | 12/18/2024 | [**Insights into the RNA Sequencing Technologies Market from 2024 to 2031 - LinkedIn**](https://www.linkedin.com/pulse/insights-rna-sequencing-technologies-market-from-2024-2031-0tnve) | [[Linkedin]] | | 12/7/2024 | [**Genotyping Market to Hit USD 59.31 Billion by 2032 with 14.27AGR - Report by S&S Insider**](https://finance.yahoo.com/news/genotyping-market-hit-usd-59-140000786.html) | [[Yahoo Finance]] | | 12/4/2024 | [**RNA Sequencing: Transforming Genomics and Shaping Future Markets - PR Newswire**](https://www.prnewswire.com/news-releases/rna-sequencing-transforming-genomics-and-shaping-future-markets-302322910.html) | [[PR Newswire]] | | 11/25/2024 | [**What's next in AI's drug discovery journey**](https://www.fiercebiotech.com/sponsored/whats-next-ais-drug-discovery-journey) | [[FierceBiotech]] | | 11/14/2024 | [**Bumrungrad International Hospital Partners with Golden Helix to Advance Genomics for Cancer and Hereditary Disease Initiatives**](https://www.prnewswire.com/news-releases/bumrungrad-international-hospital-partners-with-golden-helix-to-advance-genomics-for-cancer-and-hereditary-disease-initiatives-302304751.html) | [[PR Newswire]] | | 11/11/2024 | [**Targeted DNA/RNA Sequencing Market Size, Growth, And Industry Analysis By Market ...**](https://www.linkedin.com/pulse/targeted-dnarna-sequencing-market-size-growth-industry-analysis-nyytf) | [[Linkedin]] | | 11/7/2024 | [**New Tech Trends in Healthcare for 2025**](https://healthcareguys.com/2024/11/07/new-tech-trends-in-healthcare-for-2025/) | [[The Healthcare Guys]] | | 10/4/2024 | [**Hyper-Personalized Medicine Market Research 2024: Size, Trends, Opportunities and Forecast 2020-2024 & 2025-2030 - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241004930872/en/Hyper-Personalized-Medicine-Market-Research-2024-Size-Trends-Opportunities-and-Forecast-2020-2024-2025-2030---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 8/20/2024 | [**mRNA Sequencing Market Innovations: Comprehensive Industry Analysis, Growth Trends ...**](https://www.whatech.com/og/markets-research/medical/869062-mrna-sequencing-market-innovations-comprehensive-industry-analysis-growth-trends-and-leading-players-with-forecasts-to-2031.html) | whatech.com | | 7/11/2024 | [**MGI Tech and Predica Diagnostics Team Up for Precision RNA Sequencing in Oncology**](https://www.prnewswire.com/news-releases/mgi-tech-and-predica-diagnostics-team-up-for-precision-rna-sequencing-in-oncology-302194629.html) | [[PR Newswire]] | | 7/9/2024 | [**Pharma Pulse 7/9/24: How Real-World Data and AI Are Transforming Clinical Trials ...**](https://www.pharmexec.com/view/pharma-pulse-7-9-24-) | [[PharmExec]] | | 7/8/2024 | [**Biostate AI Launches Total RNA Sequencing and Free Data Analysis AI - Business Wire**](https://www.businesswire.com/news/home/20240708652997/en/Biostate-AI-Launches-Total-RNA-Sequencing-and-Free-Data-Analysis-AI) | [[Business Wire]] | | 7/8/2024 | [**Biostate AI Launches Total RNA Sequencing and Free Data Analysis AI**](http://www.businesswire.com/news/home/20240708652997/en/Biostate-AI-Launches-Total-RNA-Sequencing-and-Free-Data-Analysis-AI/?feedref=JjAwJuNHiystnCoBq_hl-Q-tiwWZwkcswR1UZtV7eGe24xL9TZOyQUMS3J72mJlQ7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LOzmn6JePCpHPCiYGaEx4DL1Rq8pNwkf3AarimpDzQGuQ==) | [[Business Wire]] | | 6/28/2024 | [**Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey**](https://finance.yahoo.com/news/genoks-velsera-forge-strategic-partnership-050400903.html) | [[Yahoo Finance]] | ## Topic Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **MGI Tech Co., Ltd.**: A company focused on developing advanced sequencing technologies, including RNA sequencing platforms. - **Illumina**: A leading company in the field of genomic sequencing, known for its advancements in RNA sequencing technologies. - **Biostate AI**: A startup focused on RNA sequencing and data analysis, utilizing innovative technologies for comprehensive RNA analysis. - **NUS Researchers**: Developed a novel method for analyzing single-cell RNA sequencing data, enhancing precision and speed in biomedical research. - **Parse Biosciences**: Develops scalable single-cell RNA sequencing tools and has collaborated with INTEGRA Biosciences to automate sequencing workflows. - **Wobble Genomics**: A spin-out from the University of Edinburgh focusing on innovative RNA sequencing technology. - **PacBio**: A company that launched the Vega system, a benchtop long-read sequencing platform designed for RNA sequencing and other applications. - **Broken String Biosciences**: A company that has developed the INDUCE-seq platform for RNA sequencing, aiming to expand its market presence. - **Baylor Genetics**: A clinical diagnostic laboratory specializing in genetic testing, known for its rapid Whole Genome Sequencing and newly launched RNA sequencing test for enhanced variant detection. - **MGI Tech**: Provider of next-generation genomic sequencing technologies aimed at enhancing scientific research and personalized medical treatments. - **Thermo Fisher Scientific**: A major player in the life sciences sector, providing tools and technologies for RNA sequencing and related applications. - **Oxford Nanopore Technologies**: A UK-based company known for its nanopore sequencing technology, involved in various genomic projects including Singapore's National Precision Medicine programme. - **Predica Diagnostics**: Specializes in advanced sequencing assays, particularly for cervical cancer screening. - **Oxford Nanopore**: A company that provides advanced molecular sensing technology and is involved in collaborations to enhance genomics-based translational research. ### Partnerships and Collaborations - **Biostate AI and Twist Bioscience**: Collaboration to enhance RNA sequencing capabilities and multiomic data collection. - **Singapore's National Precision Medicine programme and Oxford Nanopore**: This collaboration aims to sequence 10,000 genomes to enhance understanding of genetic diversity in Singapore's multi-ethnic population. - **MGI Tech and Predica Diagnostics**: Partnership to develop targeted RNA sequencing tests for early cancer detection. - **INTEGRA Biosciences and Parse Biosciences**: Collaboration to automate single-cell RNA sequencing using the ASSIST PLUS pipetting robot. - **NUS and Tsinghua University**: Collaborated on the development of the scAMF framework for single-cell RNA sequencing data analysis. - **Epic and GeneDx**: Working together to integrate rapid whole genome sequencing technology into Epic's EHR system for improved genomic insights in pediatric and neonatal care. - **MGI Tech and Universidad de San Martín de Porres**: Collaboration to implement advanced genomic sequencing for large-scale studies in Peru. - **MGI Tech and Sabin Group**: Collaborating to enhance health detection in Brazil through advanced genetic sequencing technology, aiming to improve personalized medicine. - **Fabric Genomics and Intermountain Children's Health**: Collaborating to analyze whole genomes of children to expedite the diagnosis of genetic diseases. - **Oxford Nanopore and UK Government**: Strategic partnership to enhance genomics-based translational research and improve patient care within the NHS. - **Baylor Genetics and HCA Healthcare**: Strategic relationship to improve genetic testing accessibility and precision diagnostics. - **Bumrungrad International Hospital and Golden Helix**: A multiyear agreement to enhance genomics initiatives in cancer and hereditary disease diagnostics. - **Sapio Sciences and CREO**: Partnership to enhance laboratory management and facilitate digital transformation in life sciences research. - **Genoks and Velsera**: Partnership to enhance cancer diagnostics and treatment in Turkey through advanced genomic analysis. - **Cofactor Genomics and Dr. Howard McLeod**: Appointment of Dr. McLeod to the advisory board to enhance precision medicine solutions in healthcare systems. - **Mayo Clinic and JelloX Biotech**: Partnering to enhance AI-powered imaging analysis technology for cancer diagnoses, focusing on improving precision in diagnostics. ### Innovations, Trends, and Initiatives - **RNA Sequencing Market Growth**: The global RNA sequencing market is projected to grow significantly due to advancements in next-generation sequencing technologies and increasing adoption in clinical settings. - **Total RNA Sequencing Technology**: Biostate AI has launched Total RNA sequencing technology that expands beyond traditional RNA sequencing methods. - **Total RNA Sequencing**: Biostate AI's new service that utilizes patent-pending BIRT technology to analyze all types of RNA comprehensively. - **Next-Generation Sequencing (NGS)**: Technological advancements in NGS are driving the growth of RNA sequencing, enabling more accurate and efficient genomic profiling. - **mRNA Sequencing Growth**: The mRNA sequencing market is expected to grow significantly due to the demand for precision medicine and advancements in sequencing technologies. - **AI Integration**: The integration of artificial intelligence in RNA sequencing data analysis is enhancing efficiency and accessibility. - **AI in RNA Sequencing**: Innovations in AI are being integrated into RNA sequencing technologies to enhance data analysis and interpretation. - **Vega System Launch**: PacBio's Vega system offers advanced RNA sequencing capabilities with a focus on data accuracy and accessibility. - **High-throughput Techniques**: The evolution from traditional RNA analysis methods to high-throughput and high-resolution transcriptome analysis is transforming research capabilities. - **Singapore National Precision Medicine Program**: Aiming to sequence 10,000 genomes to enhance understanding of local genetic diversity. - **scAMF Framework**: A new method for analyzing single-cell RNA sequencing data that reduces noise and improves biological information preservation. - **Clinical Next-Generation Sequencing Market**: Focus on advanced genomic sequencing technologies for disease diagnosis, personalized medicine, and biomarker discovery. - **Wobble Genomics' Technology**: Developed technology capable of detecting rare RNA variants with high sensitivity and specificity, contributing to early-stage cancer detection. - **CervicaDx Test**: A targeted RNA sequencing test developed by Predica Diagnostics for cervical cancer screening. - **Hyper-Personalized Medicine**: An emerging trend focusing on tailoring treatments based on individual genetic profiles, supported by advancements in RNA sequencing. - **Neoantigen Vaccines**: Innovative cancer treatment strategies utilizing advanced genomic sequencing and AI to create personalized therapies targeting unique mutations in cancer cells. ### Challenges and Concerns - **Data Complexity**: The complexity of data generated from RNA sequencing poses challenges in analysis and interpretation. - **Cost of Sequencing Services**: High costs associated with sequencing services may hinder broader adoption despite technological advancements. - **Cost of RNA Sequencing**: Despite advancements, the cost of RNA sequencing remains a concern for widespread adoption in clinical settings. - **Data Privacy and Security**: As RNA sequencing technologies advance, ensuring the privacy and security of genetic data is increasingly critical. - **Regulatory Challenges**: Evolving legislation regarding genetic data and privacy may pose challenges for RNA sequencing technologies. - **Cost of Technologies**: High costs associated with RNA sequencing technologies can limit accessibility for some healthcare systems. - **Data Security**: Concerns regarding the security of genomic data and patient privacy in RNA sequencing applications. - **Integration into Clinical Practices**: Challenges in integrating RNA sequencing technologies into existing clinical workflows and practices. - **Regulatory Factors**: The RNA sequencing market faces challenges related to regulatory compliance and the need for data accuracy. - **Standardization**: The need for standardized protocols and practices in RNA sequencing to ensure accuracy and reproducibility of results. - **Data Scarcity and Bias**: Challenges in AI-driven drug discovery and RNA sequencing analysis due to data scarcity and biases in existing datasets. - **Cost and Ethical Issues**: High costs of NGS systems and concerns regarding data confidentiality and ethical implications of genomic diagnostics. - **Access Disparities**: Significant barriers to genomic testing and tumor biopsies, particularly in underserved communities, limiting opportunities for targeted therapies. - **Integration of Genomic Data**: The need for improved interoperability standards to create a holistic view of patient health and enhance personalized care. - **Competition in the Market**: Emerging companies like Wobble Genomics face competition from established players, necessitating unique approaches to stand out. - **Ethical Concerns**: There are ongoing ethical concerns regarding genetic information privacy and the implications of AI in healthcare. - **Market Expansion Barriers**: Inadequate medical reimbursements and competition from alternative technologies may hinder market growth. ## Related Topics [[Genomic Sequencing]]